Smith & Nephew execs add shares via dividend plan

Smith & Nephew plc reported routine share acquisitions by senior management under its Dividend Re-Investment Plan.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Smith & Nephew plc reported routine share acquisitions by senior management under its Dividend Re-Investment Plan. Following the 2025 final dividend paid on 27 May 2026, the plan automatically purchased ordinary shares of USD 0.20 each on the London Stock Exchange for participating insiders.

Chief Executive Officer Deepak Nath acquired 6,259.14583 ordinary shares at a price of 11.38002 per share, while Chief Financial Officer John Rogers acquired 61.89914 shares at the same price. Other participants included President, Global Operations Paul Connolly, Chief Compliance Officer Alison Parkes, and President, Sports Medicine Scott Schaffner, each completing a single transaction through the plan.

Key Figures

Share price: 11.38002 per share CEO shares acquired: 6,259.14583 shares CFO shares acquired: 61.89914 shares +3 more

6 metrics

Share price 11.38002 per share Dividend Re-Investment Plan purchases on 27 May 2026

CEO shares acquired 6,259.14583 shares Deepak Nath purchase via Dividend Re-Investment Plan

CFO shares acquired 61.89914 shares John Rogers purchase via Dividend Re-Investment Plan

President Global Operations shares 1,190.0452 shares Paul Connolly purchase via Dividend Re-Investment Plan

Chief Compliance Officer shares 153.58792 shares Alison Parkes purchase via Dividend Re-Investment Plan

President Sports Medicine shares 2,148.33828 shares Scott Schaffner purchase via Dividend Re-Investment Plan

Key Terms

UK Market Abuse Regulation, Dividend Re-Investment Plan, PDMR, ordinary shares of USD 0.20 each

4 terms

UK Market Abuse Regulation regulatory

"This announcement is made in accordance with the UK Market Abuse Regulation"

Dividend Re-Investment Plan financial

"Purchase of ordinary shares through the Company's Dividend Re-Investment Plan"

PDMR regulatory

"Name (Position) | Director / PDMR | Price | Volume"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

ordinary shares of USD 0.20 each financial

"Smith & Nephew plc ordinary shares of USD 0.20 each"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Smith & Nephew (SNN) disclose in this 6-K?

Smith & Nephew disclosed routine insider share purchases under its Dividend Re-Investment Plan. Senior managers received ordinary shares automatically when the 2025 final dividend was paid on 27 May 2026, with each transaction executed as a single trade on the London Stock Exchange.

How many Smith & Nephew shares did CEO Deepak Nath acquire?

CEO Deepak Nath acquired 6,259.14583 Smith & Nephew ordinary shares. These were purchased at a price of 11.38002 per share through the company’s Dividend Re-Investment Plan, following the 2025 final dividend payment on 27 May 2026 on the London Stock Exchange.

What price was paid for Smith & Nephew shares in the Dividend Re-Investment Plan?

All reported Dividend Re-Investment Plan purchases were executed at a price of 11.38002 per share. This single price applied to each participating insider’s acquisition of Smith & Nephew ordinary shares when the 2025 final dividend was reinvested on 27 May 2026.

Which Smith & Nephew executives participated in the 2025 dividend reinvestment?

Participants included CEO Deepak Nath, CFO John Rogers, President Global Operations Paul Connolly, Chief Compliance Officer Alison Parkes, and President Sports Medicine Scott Schaffner. Each completed a single transaction acquiring Smith & Nephew ordinary shares via the Dividend Re-Investment Plan.

What is the nature of the Smith & Nephew insider transactions reported?

The transactions are automatic purchases through Smith & Nephew’s Dividend Re-Investment Plan. Instead of receiving cash, dividends from the 2025 final payment were used on 27 May 2026 to buy additional ordinary shares for the participating directors and senior managers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/03/2026 - 06:45 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 under the

Securities Exchange Act of 1934

June 03, 2026

Commission File Number 001-14978

SMITH & NEPHEW plc

(Registrant’s name)

Building 5, Croxley Park, Hatters Lane

Watford, England, WD18 8YE

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ✔ Form 40-F __

SMITH & NEPHEW PLC

3 June 2026

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2025 final dividend payment on 27 May 2026.
Date of Transaction	2026 - 05 - 27
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Director / PDMR	Price	Volume	Aggregated information
Deepak Nath (Chief Executive Officer)	Director	11.38002	6,259.14583	N/A Single Transaction
John Rogers (Chief Financial Officer)	Director	11.38002	61.89914	N/A Single Transaction
Paul Connolly (President, Global Operations)	PDMR	11.38002	1190.0452	N/A Single Transaction
Alison Parkes (Chief Compliance Officer)	PDMR	11.38002	153.58792	N/A Single Transaction
Scott Schaffner (President, Sports Medicine)	PDMR	11.38002	2148.33828	N/A Single Transaction

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		Smith & Nephew plc
		(Registrant)


Date: June 03, 2026	By:	/s/ Helen Barraclough
		Helen Barraclough
		Company Secretary

Source: View Original Filing on SEC EDGAR